緑内障手術装置市場- 世界の産業規模、シェア、動向、機会、予測、製品別、手術方法別、最終用途別、地域別、競合別、2020-2030年

緑内障手術装置の世界市場規模は2024年に14億4,000万米ドルとなり、2030年までCAGR 5.14％で成長すると予測されています。

この成長の主な原動力は、緑内障の世界の罹患率の上昇です。緑内障は、回復不能な失明の主な原因の一つである慢性眼疾患です。早期発見と治療の選択肢に対する認識が高まるにつれ、特に薬物療法に反応しない患者に対する外科的介入への嗜好が高まっています。世界保健機関（WHO）の2023年報告書によると、世界全体で22億人以上が何らかの視力障害に苦しんでおり、タイムリーな眼科治療と効果的な治療が非常に必要であることが明らかになっています。このような動向は、回避可能な視力低下を防ぎ、障害を受けた人々の生活の質を向上させる上で、高度な手術装置の役割が拡大していることを浮き彫りにしています。

市場促進要因

老人人口の増加

主な市場課題

代替治療法の利用可能性

主要市場動向

低侵襲緑内障手術（MIGS）の優位性

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の緑内障手術装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（パンチ、USCマーカー、USCプランナー、USCシェーバー、鉗子、歯ブラシ、プローブ、ダイヤモンドナイフ、緑内障ドレナージ装置、レーザーシステム、その他）
  • 手術方法別（従来の緑内障手術、低侵襲緑内障手術、レーザー手術）
  • 用途別（病院、眼科、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の緑内障手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の緑内障手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の緑内障手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の緑内障手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの緑内障手術装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Alcon, Inc.
• Abbott Medical Optics Pvt Ltd
• Asico LLC
• Katalyst Surgical LLC
• Ziemer Ophthalmic Systems AG
• Lumenis Ltd
• Iridex Corporation
• Carl Zeiss Meditec AG
• Allergan Plc.
• Glaukos Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Glaucoma Surgery Devices Market was valued at USD 1.44 billion in 2024 and is anticipated to grow at a CAGR of 5.14% through 2030. This growth is primarily driven by the rising global incidence of glaucoma, a chronic eye disease that is among the leading causes of irreversible blindness. With increased awareness of early detection and treatment options, there is a growing preference for surgical interventions, particularly for patients who do not respond to medications. According to the World Health Organization (WHO) 2023 report, more than 2.2 billion people suffer from some form of vision impairment globally, underscoring the critical need for timely eye care and effective treatments. These trends highlight the expanding role of advanced surgical devices in preventing avoidable vision loss and improving quality of life for affected individuals.

Key Market Drivers

Increasing Geriatric Population

The expanding global geriatric population is a major driver of the Global Glaucoma Surgery Devices Market. According to WHO, the proportion of people aged 65 and above rose from 5.5% in 1974 to 10.3% in 2024 and is projected to reach 20.7% by 2074. Since glaucoma predominantly affects older adults, the growing elderly demographic is directly linked to an increased prevalence of this condition. As life expectancy continues to rise, so does the number of individuals at risk for glaucoma, intensifying the need for early diagnosis and surgical intervention. Additionally, aging populations in both developed and emerging markets are experiencing higher healthcare access, resulting in more frequent eye screenings and subsequent treatments. Innovations in surgical techniques, particularly the rise of micro-invasive glaucoma surgery (MIGS), are also enabling safer, more effective solutions tailored to elderly patients. As this population segment expands, demand for reliable glaucoma surgery devices is expected to remain strong.

Key Market Challenges

Availability of Alternative Treatment Methods

The presence of alternative treatment methods presents a notable challenge to the growth of the Global Glaucoma Surgery Devices Market. Non-surgical interventions-particularly pharmaceutical eye drops-remain widely used due to their non-invasive nature and patient familiarity. Laser therapies, such as selective laser trabeculoplasty (SLT) and laser peripheral iridotomy (LPI), offer additional less-invasive options with shorter recovery periods, making them appealing to many patients. Furthermore, minimally invasive glaucoma surgery (MIGS) blurs the line between medical and surgical treatments, offering safer procedures that can be performed alongside cataract surgeries. These alternatives often serve as the first line of treatment, especially in early-stage cases, limiting the number of patients opting for traditional surgical devices. Factors such as patient age, comorbidities, and treatment affordability further influence the decision, often leading healthcare professionals to recommend less invasive measures initially.

Key Market Trends

Minimally Invasive Glaucoma Surgery (MIGS) Dominance

The rising adoption of Minimally Invasive Glaucoma Surgery (MIGS) is a pivotal trend reshaping the Global Glaucoma Surgery Devices Market. MIGS procedures are gaining popularity due to their less invasive approach, which involves smaller incisions, faster recovery, and reduced postoperative risks. This approach enhances patient outcomes and satisfaction, particularly among older individuals. Additionally, MIGS techniques are frequently performed alongside cataract surgery, offering a dual-benefit solution that is efficient and convenient for patients and providers. With a strong safety profile and effective intraocular pressure (IOP) reduction, MIGS has become an attractive option for managing both early and moderate stages of glaucoma. The growing preference for such procedures is prompting manufacturers to innovate and expand their MIGS device portfolios, solidifying its dominance within the surgical treatment landscape.

Key Market Players

• Alcon, Inc.
• Abbott Medical Optics Pvt Ltd
• Asico LLC
• Katalyst Surgical LLC
• Ziemer Ophthalmic Systems AG
• Lumenis Ltd
• Iridex Corporation
• Carl Zeiss Meditec AG
• Allergan Plc.
• Glaukos Corporation

Report Scope:

In this report, the Global Glaucoma Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Glaucoma Surgery Devices Market, By Product:

• Punches, USC marker, USC planner, USC shaver, Forceps, Algerbrush, Probes
• Diamond knives
• Glaucoma Drainage Device
• Laser System
• Others

Glaucoma Surgery Devices Market, By Surgery Method:

• Traditional glaucoma surgery
• Minimal invasive glaucoma surgery
• Laser surgery

Glaucoma Surgery Devices Market, By End Use:

• Hospitals
• Ophthalmic clinics
• Others

Glaucoma Surgery Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Glaucoma Surgery Devices Market.

Available Customizations:

Global Glaucoma Surgery Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers

5. Global Glaucoma Surgery Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, Glaucoma Drainage Device, Laser System, Others)
  • 5.2.2. By Surgery Method (Traditional glaucoma surgery, Minimal invasive glaucoma surgery, Laser surgery)
    • 5.2.2.1. By Traditional glaucoma surgery (Trabeculectomy, Tube shunt surgery)
    • 5.2.2.2. By Minimal invasive glaucoma surgery (Trabecular meshwork bypass, Suprachoroidal space implants, Subconjunctival space implants)
    • 5.2.2.3. By Laser surgery (Trabeculoplasty, Iridotomy, Cyclophotocoagulation)
  • 5.2.3. By End Use (Hospitals, Ophthalmic clinics, Others)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Glaucoma Surgery Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Surgery Method
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Glaucoma Surgery Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Surgery Method
      • 6.3.1.2.3. By End Use
  • 6.3.2. Mexico Glaucoma Surgery Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Surgery Method
      • 6.3.2.2.3. By End Use
  • 6.3.3. Canada Glaucoma Surgery Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Surgery Method
      • 6.3.3.2.3. By End Use

7. Europe Glaucoma Surgery Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Surgery Method
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Glaucoma Surgery Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Surgery Method
      • 7.3.1.2.3. By End Use
  • 7.3.2. Germany Glaucoma Surgery Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Surgery Method
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Glaucoma Surgery Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Surgery Method
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Glaucoma Surgery Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Surgery Method
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Glaucoma Surgery Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Surgery Method
      • 7.3.5.2.3. By End Use

8. Asia-Pacific Glaucoma Surgery Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Surgery Method
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Glaucoma Surgery Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Surgery Method
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Glaucoma Surgery Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Surgery Method
      • 8.3.2.2.3. By End Use
  • 8.3.3. South Korea Glaucoma Surgery Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Surgery Method
      • 8.3.3.2.3. By End Use
  • 8.3.4. Japan Glaucoma Surgery Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Surgery Method
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Glaucoma Surgery Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Surgery Method
      • 8.3.5.2.3. By End Use

9. South America Glaucoma Surgery Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Surgery Method
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Glaucoma Surgery Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Surgery Method
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina Glaucoma Surgery Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Surgery Method
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia Glaucoma Surgery Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Surgery Method
      • 9.3.3.2.3. By End Use

10. Middle East and Africa Glaucoma Surgery Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Surgery Method
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Glaucoma Surgery Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Surgery Method
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia Glaucoma Surgery Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Surgery Method
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE Glaucoma Surgery Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Surgery Method
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Alcon, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Product & Services
  • 15.1.4. Financials (In case of listed companies)
  • 15.1.5. Recent Developments
  • 15.1.6. SWOT Analysis
• 15.2. Abbott Medical Optics Pvt Ltd
• 15.3. Asico LLC
• 15.4. Katalyst Surgical LLC
• 15.5. Ziemer Ophthalmic Systems AG
• 15.6. Lumenis Ltd
• 15.7. Iridex Corporation
• 15.8. Carl Zeiss Meditec AG
• 15.9. Allergan Plc.
• 15.10. Glaukos Corporation

16. Strategic Recommendations

17. About Us & Disclaimer